跳至主要内容
临床试验/NCT01073514
NCT01073514Unknown不适用

Clinical Trial of Bile Etiology,Proteomics and Metabonomics of Malignant Biliary Obstruction

Tianjin Medical University Cancer Institute and Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
试验地点
1

研究概览

简要总结

To investigate bile culture and susceptibility test in patients with malignant biliary obstruction (MBO) or relation between bile, portal vein or vein culture and biliary infection. Also to get the information of bile metabonomics to find potential tumor marker .Culture of the organism is recognized as the "gold standard" for diagnosis of infection. Our research may be one of the first research on culture and susceptibility test in patients with MBO. The results of the trial research will be benefit to experiential therapy of MBO with biliary infection and diagnosis of MBO.

详细描述

We will obtain bile sample for culture and susceptibility ,proteomics metabonomics test after PTBD. Also get the blood and urine samples.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Those with MBO who can receive Percutaneous Transhepatic Biliary Drainage(PTBD)

排除标准

  • Those with MBO who cannot receive Percutaneous Transhepatic Biliary Drainage(PTBD)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验